CDEK
← All organizations

King Pharmaceuticals

For profitContributed to NME

Also known as: KING PHARMS | KING PHARMS LLC

Phase 1Phase 2Phase 3Phase 4

First marketed drug

Jan 1, 1994

First NDA

Sep 21, 1999

Last known activity

Aug 13, 2009

Acquired by Pfizer on Jan 1, 2010

Timeline

1950s

  1. Jun 1, 1951

    chloramphenicol— NDA Organization

1970s

  1. Jul 12, 1974

    trimethobenzamide— NDA Secondary Org

1990s

  1. Jun 1, 1993

    Monarch Pharmaceuticals— Acquired

  2. Jan 1, 1994

    King Pharmaceuticals— Founded

2000s

  1. Jan 1, 2000

    Jones Medical Industries— Acquired

  2. Mar 31, 2000

    methimazole— Marketing Organization

  3. May 30, 2000

    Jones Pharma— Acquired

  4. Oct 21, 2002

    Meridien Medical Technologies, Inc.— Acquired

  5. Nov 24, 2008

    Alpharma— Acquired

2010s

  1. Jan 1, 2010

    Pfizer— Acquired By

Drugs by trial phase (3 distinct, 4 trials)

Phase 4 (0 own, 1 via acquisition)

Phase 3 (0 own, 2 via acquisition)

Indications

Approved for

Marketed drugs (27)

Subsidiaries (5 direct, 6 total across the full acquisition tree)

Details

Founded
Bristol, TN, US Jan 1, 1994
First NDA
Sep 21, 1999
Last known activity
Aug 13, 2009

Designations held

  • Priority review
  • Accelerated approval

Notes

Acquired by Pfizer